Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB vs LETROZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENVATINIB vs LETROZOLE: Safety Overview

Metric LENVATINIB LETROZOLE
Total FAERS Reports 33,766 31,154
Deaths Reported 4,449 3,024
Death Rate 13.2% 9.7%
Hospitalizations 19,975 8,637
Average Patient Age 65.4 yrs 61.8 yrs
% Female Patients 55.8% 98.9%
FDA Approval Date Feb 13, 2015 Apr 19, 2012
Manufacturer Eisai Inc. NuCare Pharmaceuticals,Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription